Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | LQDA | DNTH | ||
| Company | Eidos Therapeutics Inc | Liquidia Corp | Dianthus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 56.00 | 85.36 | ||
| High | 128.49 | 57.80 | 86.11 | ||
| Low | 116.83 | 53.76 | 83.12 | ||
| Latest | 122.21 | 57.59 | 85.74 | ||
| Change | -6.23 | +0.99 | -0.41 | ||
| % Change | -4.85% | +1.75% | -0.48% | ||
| Volume | 335,500 | 2,271,500 | 419,900 | ||
| 20-Day Average Volume | 113,985 | 1,538,345 | 469,250 | ||
| Previous Close | 128.44 | 56.60 | 86.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 41.49 | 88.37 | ||
| 20-Day Raw Stochastic | 36.63% | 99.05% | 25.79% | ||
| 20-Day Relative Strength | 56.42 | 80.06 | 52.82 | ||
| Weighted Alpha | +136.62 | +162.53 | +296.80 | ||
| Today's Opinion | 88% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +36.66% since 05/06/26 | -5.18% since 05/06/26 | ||
| Low | 116.83 on 01/25/21 | 39.60 on 05/11/26 | 83.12 on 05/13/26 | ||
| High | 131.08 on 01/20/21 | 57.80 on 05/13/26 | 91.24 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +48.24% since 04/13/26 | -4.73% since 04/13/26 | ||
| Low | 116.24 on 01/05/21 | 35.80 on 04/22/26 | 82.00 on 04/29/26 | ||
| High | 132.54 on 01/04/21 | 57.80 on 05/13/26 | 96.50 on 04/16/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +50.76% since 02/13/26 | +80.89% since 02/13/26 | ||
| Low | 69.38 on 10/30/20 | 29.12 on 02/26/26 | 46.80 on 02/19/26 | ||
| High | 132.54 on 01/04/21 | 57.80 on 05/13/26 | 96.50 on 04/16/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +113.77% since 11/13/25 | +141.52% since 11/13/25 | ||
| Low | 38.44 on 07/31/20 | 26.40 on 11/14/25 | 34.29 on 11/14/25 | ||
| High | 132.54 on 01/04/21 | 57.80 on 05/13/26 | 96.50 on 04/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 5,031,400 | 4,709,476 | ||
| Shares Outstanding, K | 38,873 | 88,894 | 54,666 | ||
| Annual Sales | 26,690,000 | 158,320,000 | 2,040,000 | ||
| Annual Net Income | -37,840,000 | -68,920,000 | -162,340,000 | ||
| Last Quarter Sales | 130,000 | 92,020,000 | 460,000 | ||
| Last Quarter Net Income | -30,180,000 | 14,550,000 | -40,830,000 | ||
| 60-Month Beta | -0.16 | 0.41 | 1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.52 on 05/11/26 | -0.85 on 05/05/26 | ||
| Earnings Date | 02/24/21 | 08/11/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 379.50 | 0.00 | ||